Intervention Study of Istradefylline for the Treatment of Gait Disorders in Patients with Parkinson's Disease.
Not Applicable
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-UMIN000020288
- Lead Sponsor
- Juntendo University Shizuoka Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Dementia or a score of <=23 on the Mini-Mental State Examination (MMSE) 2)Gait disturbance due to causes other than the underlying disease 3)Severe dyskinesia as assessed by the investigator or subinvestigator 4)Current treatment with istradefylline 5)Moderate to severe hepatic disorder or current treatment with a strong inhibitor of CYP3A4 6)Ongoing treatment with deep brain stimulation (DBS) and a condition requiring stimulation 7)Lactating, pregnant, or possibly pregnant women 8)Other conditions judged by the investigator or subinvestigator to be unsuitable for participation in the research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method